Pathway-focused proteomic signatures in HER2-overexpressing breast cancer with a basal-like phenotype: new insights into de novo resistance to trastuzumab (Herceptin). (Q39674865)
Jump to navigation
Jump to search
scientific article published on September 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pathway-focused proteomic signatures in HER2-overexpressing breast cancer with a basal-like phenotype: new insights into de novo resistance to trastuzumab (Herceptin). |
scientific article published on September 2010 |
Statements
Pathway-focused proteomic signatures in HER2-overexpressing breast cancer with a basal-like phenotype: new insights into de novo resistance to trastuzumab (Herceptin) (English)
Cristina Oliveras-Ferraros
Alejandro Vazquez-Martin
Begoña Martin-Castilló
Maria Carmen Pérez-Martínez
Silvia Cufí
Sonia Del Barco
Luis Bernado
Eugeni López-Bonet
Javíer A Menendez
1 September 2010